{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:04:13Z","timestamp":1760061853660},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Chromatogr Sci"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1093\/chromsci\/bmw070","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T01:14:02Z","timestamp":1465002842000},"page":"1277-1281","source":"Crossref","is-referenced-by-count":4,"title":["Simultaneous Determination of Genotoxic Impurities in Fudosteine Drugs by GC\u2013MS"],"prefix":"10.1093","volume":"54","author":[{"given":"Amarnatha Reddy","family":"Gooty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain Reddy","family":"Katreddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavender Reddy","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raveendra K.","family":"Hunnur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra Kumar","family":"Masani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"2016090704095191000_54.8.1277.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2004.11.002"},{"key":"2016090704095191000_54.8.1277.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.03.022"},{"key":"2016090704095191000_54.8.1277.3","unstructured":"European Medicines Evaluation Agency. Guideline on the limits of genotoxic impurities, CPMP\/SWP\/5199\/02 , Committee for Medicinal Products for Human Use (CHMP), London, June 28, (2006)."},{"key":"2016090704095191000_54.8.1277.4","unstructured":"Genotoxic and carcinogenic impurities in drug substances and Products; Recommended Approaches, FDA Center for Drug Evaluation and Research, Guidance for Industry (Draft), December 03, (2008)."},{"key":"2016090704095191000_54.8.1277.5","unstructured":"ICH guideline: Impurities in New drug substances Q3A, (R2), ICH guideline; Impurities in new drug products Q3B, (R2), International Conference on Harmonisation, (2006)."},{"key":"2016090704095191000_54.8.1277.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2005.12.001"},{"key":"2016090704095191000_54.8.1277.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2007.06.008"},{"key":"2016090704095191000_54.8.1277.8","first-page":"282","article-title":"The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development","volume":"44","author":"Dobo","year":"2006","journal-title":"Toxicity and Drug Testing"},{"key":"2016090704095191000_54.8.1277.9","first-page":"1561","article-title":"HPLC determination of fudosteine tablets","volume":"25","author":"Ran","year":"2005","journal-title":"Chinese Journal of Pharmaceutical Analysis"},{"key":"2016090704095191000_54.8.1277.10","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1028"},{"key":"2016090704095191000_54.8.1277.11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchromb.2008.03.017","article-title":"High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format","volume":"867","author":"Wen","year":"2008","journal-title":"Journal of Chromatography B"},{"key":"2016090704095191000_54.8.1277.12","unstructured":"International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use, ICH harmonized tripartite guideline, Validation of analytical procedures: Text and methodology, Q2 (R1), step 4 (2005)."}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/54\/8\/1277\/16725280\/bmw070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:57:42Z","timestamp":1503565062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article-lookup\/doi\/10.1093\/chromsci\/bmw070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":12,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,16]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1093\/chromsci\/bmw070"],"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmw070","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]}}}